Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition
Status:
Completed
Trial end date:
2021-03-11
Target enrollment:
Participant gender:
Summary
To evaluate and compare the relative plasma bioavailability and therefore the bioequivalence
of two different immediate release products each containing Aripiprazole 10 mg, after
administering a single oral dose, to healthy adult subjects under fasting conditions.